• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

COVID-19 Pandemic: The Surprise Catalyst for Telemedicine Adoption

by Healthcare Growth Partners (HGP) 05/08/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

It is no secret that technology adoption in healthcare often lags adoption in other sectors.  Often, the slow pace of adoption makes sense.  While technology can drastically improve both cost and quality in healthcare when implemented correctly, it can also cause physician burnout, increased administrative workload, and worsen patient outcomes if a new technology fails to live up to the hype. 

Historically, the slow pace of IT adoption in healthcare was nowhere more apparent than in the adoption of telemedicine.  While nearly every other industry adopted widespread use of conference calls, and more recently video chats, in order to collaborate remotely, healthcare providers and patients were both hesitant to adopt these tools to deliver healthcare. 

Furthermore, the slow pace of regulatory change around patient privacy and reimbursement provided significant barriers to adoption.  COVID-19 has changed all these dynamics in a matter of weeks.  Telemedicine has seen a sudden spike in adoption, with many health systems reporting that over half of primary care visits are now being performed via Telemedicine.

With this seismic shift in telemedicine, we will explore whether these changes have made any impact on the volume or value of investments into telemedicine technologies.  In order to understand investment into telemedicine, we’ll first take a look at broader Health IT M&A and investment trends in the HGP Health IT database to understand how COVID-19 has impacted the market.

As can be seen in the chart above, April transaction activity is down significantly compared to both January and the 2019 average.  February and March saw some resilience to the downward trend as committed deals went through, but April is a testament to how sharply deal flow has dropped in today’s market.  With this context, we can now look at telemedicine and how quickly investors have responded to the shift in demand for telemedicine products.

While both the volume and value of investments have declined on the whole, telemedicine has been extremely resistant to these trends. Prior to COVID-19, Telemedicine had represented less than 20% of deals on average.  Since February, the number of telemedicine investments has increased to over 30% of investment activity in Health IT.  Similarly, while the total value of invested capital has declined to less than $400mm in April, telemedicine investments represented nearly 40% of that capital.  In terms of absolute volume and value, telemedicine activity has stayed extremely resilient despite the dire economic downturn we have seen since February.

As telemedicine adoption continues to grow, HGP expects to continue to see strong investment.  The thesis around telemedicine has never been stronger, and while COVID-19 has been extremely disruptive across the economy, telemedicine is one of the rare sectors that will see COVID-19 as a net positive influence as we adapt as a society to the situation at hand.

Public Company Performance

HGP tracks stock indices for publicly traded health IT companies within four different sectors – Health IT, Payers, Healthcare Services, and Health IT & Payer Services. The chart below summarizes the performance of these sectors compared to the S&P 500 for the month of April:

The following table includes summary statistics on the four sectors tracked by HGP for April 2020:


About Healthcare Growth Partners (HGP)

Healthcare Growth Partners (HGP) is a Houston, TX-based Investment Banking & Strategic Advisory firm exclusively focused on the transformational Health IT market. The firm provides  Sell-Side Advisory, Buy-Side Advisory, Capital Advisory, and Pre-Transaction Growth Strategy services, functioning as the exclusive investment banking advisor to over 100 health IT transactions representing over $2 billion in value since 2007.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19), Health IT, Health Systems, healthcare growth, Healthcare Growth Partners (HGP), M&A, Partners, patient privacy, Payers, Physician Burnout, Primary Care, telemedicine, video

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

10 Critical KPIs Every Successful Healthcare Organization is Implementing10 Critical KPIs Every Successful Healthcare Organization is Implementing

How to Build Hybrid Care Models Around Remote Patient Monitoring

How to Build Hybrid Care Models Around Remote Patient Monitoring

Most Popular

M&A: Florence Acquires Virtual Care Solution Zipnosis

M&A: Florence Acquires Virtual Care Solution Zipnosis

Adopting Value-Based Care Models for Autism Care Is Imperative

Why Adopting Value-Based Care Models for Autism Care Is Imperative

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

Vanderbilt University Medical Center Taps Philips Reduce Carbon Footprint

Vanderbilt University Medical Center Taps Philips to Reduce Carbon Footprint

Denials Management Named Most Time-Consuming Task in RCM

Denials Management Named Most Time-Consuming Task in RCM

How AI Can Eliminate Surprise Bills, Improve Payment Integrity

AI Can Eliminate Surprise Bills, Improve Payment Integrity

Q/A: IQVIA’s Global Lead Talks Unlocking AI for Drug Repurposing

M&A: Kaiser Acquires Geisinger, Forms Risant Health

5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal

Digital Health Executive Hires & Departures

Digital Health Executive Hires & Departures: Ed Marx Departure, Particle Health CEO, Rhapsody CFO, Others

Catalyst by Wellstar Launches $100M Digital Health Venture Fund

Catalyst by Wellstar Launches $100M Digital Health Venture Fund

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |